Endocrinology News and Research

Latest Endocrinology News and Research

SNM commends the U.S. House of Representatives for its passage of medical isotope legislation

SNM applauds the U.S. House of Representatives for its passage of H.R. 3276-the American Medical Isotopes Production Act of 2009.

7 Nov 2009

Halozyme Therapeutics announces results of its insulin variability study

Halozyme Therapeutics, Inc. today announced insulin variability study results that demonstrated reduced intrasubject absorption variability for the combination of lispro, a meal time analog insulin, plus PH20 (hyaluronidase) compared to subcutaneous injection of lispro alone.

7 Nov 2009

Elevated PSA levels in men are not necessarily a predictor of the need for a prostate biopsy: Study

Researchers at Wake Forest University School of Medicine and the University of Wisconsin-Madison have discovered that some elevated prostate-specific antigen (PSA) levels in men may be caused by a hormone normally occurring in the body, and are not necessarily a predictor of the need for a prostate biopsy.

7 Nov 2009

AARP urge Idaho's U.S. Representatives to support health care reform legislation

As the debate over health care reform reaches a fevered pitch and the House readies to vote on critical health care reform legislation in the coming days - AARP is calling on Idaho's U.S. Representatives to support the bill. The AARP-backed Affordable Health Care for America Act (H.R. 3962), which will close the Medicare prescription drug "doughnut hole" and tackle soaring insurance premiums, serves to help hundreds of thousands of Idahoans.

6 Nov 2009

Third-quarter 2009 financial results announced by Halozyme Therapeutics

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets, today reported financial results for the three and nine months ended September 30, 2009.

6 Nov 2009

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

The first public data on Ossulin™ a new oral insulin product, will be presented today at the 9th Annual Diabetes Technology Meeting in San Francisco, CA. Ossulin™ is being developed by Puredel Limited, a joint-venture between the European pharmaceutical specialty company CM&D Pharma Limited and Natreon Inc., New Brunswick, NJ., developers of the proprietary delivery platform.

6 Nov 2009

Journal of Public Health Management presents new ideas for building better public health workforce

A recent special supplement to the Journal of Public Health Management calls attention to the country's pressing need for a larger and fully capable public health workforce. The supplement, written by the leading academic voices in public health and published by Lippincott Williams & Wilkins (LWW), also sheds light on the challenges the U.S. faces in adequately meeting public health needs.

6 Nov 2009

Pharmacists are necessary to the medical care model

Roger Merrill, MD, chief medical officer of Perdue Foods Inc. of Salisbury, Md., told students at the University of Maryland School of Pharmacy yesterday that they should be concerned about future health care costs.

6 Nov 2009

Dentists can play a live-saving role by identifying patients at risk of fatal heart attacks: Study

A new study indicates dentists can play a potentially life-saving role in health care by identifying patients at risk of fatal heart attacks and referring them to physicians for further evaluation.

6 Nov 2009

CPEX Pharmaceuticals to feature Nasulin at the Diabetes Technology Meeting

CPEX Pharmaceuticals, Inc. today announced that its intranasal insulin product candidate, NasulinTM, will be featured in an oral presentation and four abstracts at the Ninth Annual Diabetes Technology Meeting, November 5-7, 2009 at the Hyatt Regency Airport in San Francisco, California.

6 Nov 2009

Wedgewood Pharmacy announces compounding of thyroid tablets in response to physician demand

Wedgewood Pharmacy announced today that it is compounding thyroid tablets in response to physician demand during the long-term backorder of Forest Laboratories’ Armour® Thyroid tablets. Compounded using Thyroid USP powder, a naturally occurring thyroid, Wedgewood Pharmacy’s scored tablets are available by prescription in 15mg, 30mg, 60mg and 120mg, with prices ranging from $21 to $25 per 100-count bottle.

6 Nov 2009

Physical education plays a key role for low-income communities in curbing obesity and improving fitness

School-based physical education plays a key role in curbing obesity and improving fitness among adolescents from low-income communities, according to a new study led by researchers at the University of California, San Francisco and UC Berkeley.

6 Nov 2009

Arthur H. Rubenstein to receive the Abraham Flexner Award

Arthur H. Rubenstein, MBBCh, Executive Vice President of the University of Pennsylvania for the Health System, and Dean, School of Medicine, will receive the Abraham Flexner Award for Distinguished Service to Medical Education from the Association of American Medical Colleges (AAMC).

6 Nov 2009

Soda and other sugar-sweetened beverages linked to obesity; soda industry fails to acquit itself in landmark hearings

In today’s landmark hearings called by State Senators Alex Padilla (D-Pacoima) and Elaine Kontominas Alquist (D-San Jose), representatives from the soda industry failed to acquit themselves of a growing body of research implicating sugar-sweetened beverages as the leading culprit in the obesity epidemic.

6 Nov 2009

Revised Management Guidelines for diagnosing and treating thyroid cancer released

The American Thyroid Association has released new, revised Management Guidelines for the diagnosis and treatment of patients with thyroid nodules and thyroid cancer. The new guidelines are published in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com).

6 Nov 2009

$1.85 million grant to study how digital games can improve players' health behaviors and outcomes

The Robert Wood Johnson Foundation (RWJF) today announced more than $1.85 million in grants for research that will offer unprecedented insight into how digital games can improve players' health behaviors and outcomes. With funding from RWJF's Health Games Research national program, nine research teams across the country will conduct extensive studies to discover, for example, how the popular dance pad video game Dance Dance Revolution might help Parkinson's patients reduce the risk of falling, how Wii Active might be most effectively implemented in high schools to help overweight students lose weight, how a mobile phone game with a breath interface might help smokers quit or reduce their tobacco use, or how facial recognition games might be designed to help people with autism learn to identify others' emotions.

From Evident Corporation - Life Sciences 6 Nov 2009

Declining kidney function linked to higher risk of heart failure in individuals with or without kidney disease

Declining kidney function is linked to a higher risk of heart failure, heart attack, peripheral arterial disease, and early death in individuals with or without kidney disease, according to a pair of studies appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

6 Nov 2009

Senators make health reform positions known

The New Orleans Times-Picayune reports that a "health care overhaul faces a tough sell among the Louisiana delegation:" "Sen. Mary Landrieu, D-La., said the bill pending ... isn't aggressive enough in trying to curb rising health care costs. But she also said that doing nothing is not an option with so many Louisiana families and small businesses unable to afford health coverage.

6 Nov 2009

UCSF HIV researchers receive two NIH grants to improve health of HIV positive patients

UCSF HIV researchers have received two NIH grants of $1 million each to study the use of web-based, patient controlled personal health records to improve health and HIV prevention outcomes for HIV positive patients.

6 Nov 2009

FDA clears ARKRAY's new GLUCOCARD Vital blood glucose monitoring system

ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced that it has received 510(k) clearance from the US Food and Drug Administration for its new GLUCOCARD Vital blood glucose monitoring system.

5 Nov 2009

Endocrinology News and Research

Latest Endocrinology News and Research

SNM commends the U.S. House of Representatives for its passage of medical isotope legislation

Halozyme Therapeutics announces results of its insulin variability study

Elevated PSA levels in men are not necessarily a predictor of the need for a prostate biopsy: Study

AARP urge Idaho's U.S. Representatives to support health care reform legislation

Third-quarter 2009 financial results announced by Halozyme Therapeutics

Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting

Journal of Public Health Management presents new ideas for building better public health workforce

Pharmacists are necessary to the medical care model

Dentists can play a live-saving role by identifying patients at risk of fatal heart attacks: Study

CPEX Pharmaceuticals to feature Nasulin at the Diabetes Technology Meeting

Wedgewood Pharmacy announces compounding of thyroid tablets in response to physician demand

Physical education plays a key role for low-income communities in curbing obesity and improving fitness

Arthur H. Rubenstein to receive the Abraham Flexner Award

Soda and other sugar-sweetened beverages linked to obesity; soda industry fails to acquit itself in landmark hearings

Revised Management Guidelines for diagnosing and treating thyroid cancer released

$1.85 million grant to study how digital games can improve players' health behaviors and outcomes

Declining kidney function linked to higher risk of heart failure in individuals with or without kidney disease

Senators make health reform positions known

UCSF HIV researchers receive two NIH grants to improve health of HIV positive patients

FDA clears ARKRAY's new GLUCOCARD Vital blood glucose monitoring system

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Endocrinology News and Research

Latest Endocrinology News and Research

Industry Focus eBook - Pharmaceutical manufacturing (2nd edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in